A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
2020 · Nature · 1,483 citations
https://doi.org/10.1038/s41586-020-2381-y
J
Jianxun Qi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
401
Papers
24.3K
Citations
73
h-index
233
i10-index
Jianxun Qi is an academic researcher from Nanjing Normal University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Influenza Virus Research Studies & Viral gastroenteritis research and epidemiology. The author has an h-index of 73, co-authored 341 publications.
ORCID: 0000-0002-9358-4732Papers by this author
worksAn unexpected N-terminal loop in PD-1 dominates binding by nivolumab
2017 · Nature Communications · 252 citations
https://doi.org/10.1038/ncomms14369
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
2021 · Nature Communications · 178 citations
https://doi.org/10.1038/s41467-021-26401-w
Human infection of avian influenza A H3N8 virus and the viral origins: a descriptive study
2022 · The Lancet Microbe · 160 citations
https://doi.org/10.1016/s2666-5247(22)00192-6
Structure of monkeypox virus DNA polymerase holoenzyme
2022 · Science · 106 citations
https://doi.org/10.1126/science.ade6360
Airborne transmission of human-isolated avian H3N8 influenza virus between ferrets
2023 · Cell · 88 citations
https://doi.org/10.1016/j.cell.2023.08.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat